Nathaniel Calloway
Director/Board Member at ANEBULO PHARMACEUTICALS, INC.
Net worth: 149 046 $ as of 31/03/2024
Profile
Nathaniel Calloway is currently the Director at Lifecore Biomedical, Inc., an Independent Director at Anebulo Pharmaceuticals, Inc., and a Healthcare Analyst at 22NW LP.
Previously, he worked as an Analyst at Edison Investment Research, Inc. from 2015 to 2021.
Dr. Calloway holds a graduate degree from The Trustees of Columbia University in The City of New York, a doctorate degree from Cornell University, and an undergraduate degree from The University of North Carolina at Chapel Hill (conferred in 2004).
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 01/02/2024 | 28,069 ( 0.09% ) | 149 046 $ | 31/03/2024 |
Nathaniel Calloway active positions
| Companies | Position | Start |
|---|---|---|
| ANEBULO PHARMACEUTICALS, INC. | Director/Board Member | 01/11/2022 |
| LIFECORE BIOMEDICAL, INC. | Director/Board Member | 09/01/2023 |
22NW LP
 22NW LP Investment ManagersFinance 22NW LP is an independent registered hedge fund manager headquartered in Seattle, Washington. The firm was founded by Aron English in 2015. It provides investment advice and management to a pooled investment vehicle. | Analyst-Equity | 01/06/2021 |
Former positions of Nathaniel Calloway
| Companies | Position | End |
|---|---|---|
Edison Investment Research, Inc.
 Edison Investment Research, Inc. Investment ManagersFinance Edison Investment Research, Inc. is an investment research firm located in New York City. The firm is a subsidiary of Edison Investment Research Ltd., a leading international investment research firm. The firm writes on more than 350 companies across every sector and works directly with corporates, fund managers, investment banks, brokers and other advisers. Edison's research is read by institutional investors, alternative funds and wealth managers in more than 100 countries. | Analyst-Equity | 01/06/2021 |
Training of Nathaniel Calloway
| The Trustees of Columbia University in The City of New York | Graduate Degree |
| Cornell University | Doctorate Degree |
| The University of North Carolina at Chapel Hill | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| LIFECORE BIOMEDICAL, INC. | Health Technology |
| ANEBULO PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Edison Investment Research, Inc.
Edison Investment Research, Inc. Investment ManagersFinance Edison Investment Research, Inc. is an investment research firm located in New York City. The firm is a subsidiary of Edison Investment Research Ltd., a leading international investment research firm. The firm writes on more than 350 companies across every sector and works directly with corporates, fund managers, investment banks, brokers and other advisers. Edison's research is read by institutional investors, alternative funds and wealth managers in more than 100 countries. | Finance |
22NW LP
22NW LP Investment ManagersFinance 22NW LP is an independent registered hedge fund manager headquartered in Seattle, Washington. The firm was founded by Aron English in 2015. It provides investment advice and management to a pooled investment vehicle. | Finance |
- Stock Market
- Insiders
- Nathaniel Calloway
